174 related articles for article (PubMed ID: 37714559)
1. New-onset minimal change disease following the Moderna COVID-19 vaccine.
Kobayashi N; Fujisawa H; Kumagai J; Tanabe M
BMJ Case Rep; 2023 Sep; 16(9):. PubMed ID: 37714559
[TBL] [Abstract][Full Text] [Related]
2. Minimal change disease following the Moderna COVID-19 vaccine: first case report.
Thappy S; Thalappil SR; Abbarh S; Al-Mashdali A; Akhtar M; Alkadi MM
BMC Nephrol; 2021 Nov; 22(1):376. PubMed ID: 34763669
[TBL] [Abstract][Full Text] [Related]
3. A de novo case of minimal change disease following the first dose of the Moderna mRNA-1273 SARS-CoV-2 vaccine without relapse after the second dose.
Mochizuki RI; Takahashi N; Ikenouchi K; Shoda W; Kuyama T; Takahashi D
CEN Case Rep; 2022 Nov; 11(4):477-481. PubMed ID: 35435622
[TBL] [Abstract][Full Text] [Related]
4. Exacerbation of Minimal Change Disease Following mRNA COVID-19 Vaccination.
Pirzadeh A; Emami S; Zuckerman JE; Nobakht N
Am J Case Rep; 2023 Nov; 24():e941621. PubMed ID: 37941318
[TBL] [Abstract][Full Text] [Related]
5. New-onset Nephrotic Syndrome after Janssen COVID-19 Vaccination: a Case Report and Literature Review.
Lim JH; Han MH; Kim YJ; Kim MS; Jung HY; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
J Korean Med Sci; 2021 Aug; 36(30):e218. PubMed ID: 34342187
[TBL] [Abstract][Full Text] [Related]
6. Relapse of minimal change disease following the third mRNA COVID-19 vaccination: a case report and literature review.
Teragaki M; Tanaka M; Yamamoto H; Watanabe T; Takeoka J; Fukumi A; Maeda K; Takami Y; Saita H; Iwanari S; Ikeda M; Takeoka H
CEN Case Rep; 2024 Feb; 13(1):53-58. PubMed ID: 37244881
[TBL] [Abstract][Full Text] [Related]
7. Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.
Lebedev L; Sapojnikov M; Wechsler A; Varadi-Levi R; Zamir D; Tobar A; Levin-Iaina N; Fytlovich S; Yagil Y
Am J Kidney Dis; 2021 Jul; 78(1):142-145. PubMed ID: 33839200
[TBL] [Abstract][Full Text] [Related]
8. Pembrolizumab-associated nephrotic syndrome recovered from transient hemodialysis in a patient with lung cancer.
Ishibuchi K; Iwakura T; Kaneko M; Fukasawa H; Furuya R
CEN Case Rep; 2020 Aug; 9(3):215-219. PubMed ID: 32170578
[TBL] [Abstract][Full Text] [Related]
9. Pediatric Minimal Change Disease and AKI following the Pfizer-BioNTech COVID-19 Vaccine: causal or incidental correlation?
Annicchiarico Petruzzelli L; Minale B; Serio V; De Luca A; Marino Marsilia G; Campione S; Diomedi Camassei F; D'Arcangelo R; Luongo I; Lepore L; Giannattasio P; Molino D; Pirro L; Lonardo MC; Malgieri G; Pecoraro C
G Ital Nefrol; 2022 Dec; 39(6):. PubMed ID: 36655832
[TBL] [Abstract][Full Text] [Related]
10. Minimal-change nephrotic syndrome associated with systemic lupus erythematosus.
Makino H; Haramoto T; Shikata K; Ogura T; Ota Z
Am J Nephrol; 1995; 15(5):439-41. PubMed ID: 7503146
[TBL] [Abstract][Full Text] [Related]
11. Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine.
Holzworth A; Couchot P; Cruz-Knight W; Brucculeri M
Kidney Int; 2021 Aug; 100(2):463-464. PubMed ID: 34048824
[No Abstract] [Full Text] [Related]
12. Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with
Medjeral-Thomas NR; Lawrence C; Condon M; Sood B; Warwicker P; Brown H; Pattison J; Bhandari S; Barratt J; Turner N; Cook HT; Levy JB; Lightstone L; Pusey C; Galliford J; Cairns TD; Griffith M
Clin J Am Soc Nephrol; 2020 Feb; 15(2):209-218. PubMed ID: 31953303
[TBL] [Abstract][Full Text] [Related]
13. [Minimal change nephrotic syndrome complicated with recurrence of malignant thymoma: an interesting case with remission due to steroid therapy of both nephrotic syndrome and thymoma].
Fukuda A; Sato Y; Iwatsubo S; Komatsu H; Nishiura R; Fukudome K; Yamada K; Hara S; Fujimoto S; Kitamura K
Nihon Jinzo Gakkai Shi; 2009; 51(2):130-7. PubMed ID: 19378799
[TBL] [Abstract][Full Text] [Related]
14. Systemic lupus erythematosus in a patient with remitting minimal change nephrotic syndrome.
Nishihara G; Nakamoto M; Yasunaga C; Takeda K; Matsuo K; Urabe M; Goya T; Sakemi T
Clin Nephrol; 1997 Nov; 48(5):327-30. PubMed ID: 9403219
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Efficacy and Safety of Tacrolimus and Low-Dose Corticosteroid with High-Dose Corticosteroid for Minimal Change Nephrotic Syndrome in Adults.
Chin HJ; Chae DW; Kim YC; An WS; Ihm C; Jin DC; Kim SG; Kim YL; Kim YS; Kim YG; Koo HS; Lee JE; Lee KW; Oh J; Park JH; Jiang H; Lee H; Lee SK
J Am Soc Nephrol; 2021 Jan; 32(1):199-210. PubMed ID: 33168602
[TBL] [Abstract][Full Text] [Related]
16. Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases.
Hartley JL; Bailey N; Sharma A; Shawki H
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35246429
[TBL] [Abstract][Full Text] [Related]
17. [Complete remission of minimal change nephrotic syndrome with type 2 diabetes mellitus treated by microemulsion formulation of cyclosporin and fluvastatin].
Makibayashi K; Fukatsu A; Kita T
Nihon Jinzo Gakkai Shi; 2002 Mar; 44(2):109-13. PubMed ID: 11974950
[TBL] [Abstract][Full Text] [Related]
18. Minimal Change Disease With Severe Acute Kidney Injury Following the Oxford-AstraZeneca COVID-19 Vaccine: A Case Report.
Leclerc S; Royal V; Lamarche C; Laurin LP
Am J Kidney Dis; 2021 Oct; 78(4):607-610. PubMed ID: 34242687
[TBL] [Abstract][Full Text] [Related]
19. De Novo Minimal Change Disease following Vaccination with the Pfizer/BioNTech SARS-CoV-2 Vaccine in a Living Kidney Donor.
Marinaki S; Kolovou K; Liapis G; Skalioti C; Tsiakas S; Boletis I
Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056345
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome.
Westhoff TH; Schmidt S; Zidek W; Beige J; van der Giet M
Clin Nephrol; 2006 Jun; 65(6):393-400. PubMed ID: 16792133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]